Chief Executive Officer
Christoph Schweizer is CEO of Boston Consulting Group (BCG), elected May 2021. Prior to this role, he was BCG’s chairman for Central and Eastern Europe and the Middle East. He has also served as a member of the firm's Executive and Operating Committees since 2014.
Christoph is a member of several leading organizations, including the Business Roundtable and the World Economic Forum’s International Business Council. For the past three years, INvolve People recognized Christoph as a HERoes Advocate Executive Role Model for his work with Women@BCG related to the hiring, promotion, and retention of women.
Throughout his career, Christoph has supported clients in health care and private equity, and across industries in major transformational programs such as digital transformations and post-merger integrations. He is a passionate supporter of a wide range of social impact activities, in particular related to sustainability and fighting climate change.
Christoph joined BCG in 1997, first in Munich, and then New York from 2007 to 2012, before returning to Munich. He received an MBA from University of Texas at Austin’s McCombs School of Business and holds a BA from WHU – Otto Beisheim School of Management in Koblenz.
Multiple scenarios for the US and four EU countries point to a continued need for COVID-19 testing through 2024, with demand peaking in the seasonally affected first quarters of 2021 and 2022.
Globalization isn’t dying; it’s changing. Companies that base their strategies on an outdated narrative risk missing some of the world’s biggest growth opportunities.
Medtech has been a late bloomer in emerging markets, but as demand for health care in these regions increases, local medtech companies are positioned for success.
A new focus on value is fundamentally changing the terms of competition in the health care market. The winners will be organizations that compete on outcomes.